128
Participants
Start Date
January 15, 2025
Primary Completion Date
September 15, 2025
Study Completion Date
October 15, 2025
Nalbuphine
this group will a single dose of nalbuphine (0.2 mg/kg) immediately after surgery to be repeated every 8 hours for the duration of the study (72 hours)
Tramadol
this group will receive a single dose of tramadol (2 mg/kg) immediately after surgery to be repeated every 8 hours for the duration of the study (72 hours).
RECRUITING
National cancer institute, Cairo
National Cancer Institute, Egypt
OTHER